Pere Simonet

2.0k total citations · 2 hit papers
26 papers, 1.3k citations indexed

About

Pere Simonet is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Pere Simonet has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 4 papers in Infectious Diseases. Recurrent topics in Pere Simonet's work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Respiratory Support and Mechanisms (9 papers) and Asthma and respiratory diseases (8 papers). Pere Simonet is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Respiratory Support and Mechanisms (9 papers) and Asthma and respiratory diseases (8 papers). Pere Simonet collaborates with scholars based in Spain, France and Czechia. Pere Simonet's co-authors include Marc Miravitlles, P. Dellamonica, Philippe Halfon, Philippe Clevenbergh, Pascal Del-Giudice, CAB Boucher, N Montagne, J. Durant, Jesús Molina and David Rigau and has published in prestigious journals such as The Lancet, Environmental Research and BMJ Open.

In The Last Decade

Pere Simonet

24 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

1999 559 citations J. Durant, Philippe Clevenbergh et al. The Lancet profile →
Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable

2017 294 citations Marc Miravitlles, Juan José Soler‐Cataluña et al. Archivos de Bronconeumología profile →

Peers

Countries citing papers authored by Pere Simonet

Since Specialization

Citations

This map shows the geographic impact of Pere Simonet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Simonet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Simonet more than expected).

Fields of papers citing papers by Pere Simonet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Simonet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Simonet. The network helps show where Pere Simonet may publish in the future.

Co-authorship network of co-authors of Pere Simonet

This figure shows the co-authorship network connecting the top 25 collaborators of Pere Simonet. A scholar is included among the top collaborators of Pere Simonet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pere Simonet. Pere Simonet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of neighbourhood-level sociodemographic and socioeconomic characteristics on the physical activity of people with chronic obstructive pulmonary disease 2025 ·ERJ Open Research ·(unknown), Laura Delgado‐Ortiz, Ane Arbillaga‐Etxarri, Elena Gimeno‐Santos, Eva Balcells, (unknown), Jordi Vilaró, Diego A. Rodríguez, Robert Rodriguez-Roisín, Pere Simonet, Pere Vall‐Casas, Judith García‐Aymerich	0
2	Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD 2025 ·Archivos de Bronconeumología ·Marc Miravitlles, Myriam Calle Rubio, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Trigueros, (unknown), Borja G. Cosío, Ciro Casanova, (unknown), Juan Antonio Riesco, Pere Simonet, David Rigau, (unknown), Mariano Sanz, Patricia Sobradillo, Bernardino Alcázar Navarrete, Noé Garín, Juan José Soler‐Cataluña	1
3	[Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome 2022 ·Archivos de Bronconeumología ·Juan José Soler‐Cataluña, Pascual Piñera, Juan Antonio Trigueros, Myriam Calle Rubio, Ciro Casanova, Borja G. Cosío, José Luís López-Campos, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea, Marc Miravitlles	20
4	Infectious diseases experts as part of the antibiotic stewardship team in primary care: protocol for a cluster-randomised blinded study (IDASP) 2021 ·BMJ Open ·(unknown), Ariadna Padullés, Pere Simonet, G. Rodríguez, (unknown), (unknown), (unknown), (unknown), Fé Tubau, (unknown), (unknown), Montserrat López, (unknown), Natàlia Pallarés, Cristian Tebé, Jordi Carratalà, Mireia Puig‐Asensio, Evelyn Shaw	0
5	Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable 2021 ·Archivos de Bronconeumología ·Marc Miravitlles, Myriam Calle Rubio, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, José Luís López-Campos, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea, Juan José Soler‐Cataluña	111
6	Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC 2021 ·Archivos de Bronconeumología ·Juan José Soler‐Cataluña, Pascual Piñera, Juan Antonio Trigueros, Myriam Calle Rubio, Ciro Casanova, Borja G. Cosío, José Luís López-Campos, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea, Marc Miravitlles	22
7	Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD 2021 ·Archivos de Bronconeumología ·Marc Miravitlles, Myriam Calle Rubio, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, José Luís López-Campos, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea, Juan José Soler‐Cataluña	10
8	Recursos asistenciales en atención primaria para manejo del asma: proyecto Asmabarómetro 2018 ·Atención Primaria ·Jesús Molina, (unknown), (unknown), Pere Simonet, Carlos Campo	4
9	Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease 2017 ·Archivos de Bronconeumología ·Marc Miravitlles, Juan José Soler‐Cataluña, Myriam Calle Rubio, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea	59
10	Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable breakdown → 2017 ·Archivos de Bronconeumología ·Marc Miravitlles, Juan José Soler‐Cataluña, Myriam Calle Rubio, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea	294
11	Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study 2016 ·Respiratory Medicine ·Mónica Monteagudo, Teresa Rodríguez-Blanco, Míriam Barrecheguren, Pere Simonet, Marc Miravitlles	52
12	Diagnosis of alpha-1 antitrypsin deficiency: a population-based study 2016 ·International Journal of COPD ·Marc Miravitlles, Míriam Barrecheguren, Mónica Monteagudo, Pere Simonet, Carl Llor, Esther Rodríguez, Jaume Ferrer, Cristina Esquinas	18
13	Prevalencia de portadores nasales de Staphylococcus aureus y Streptococcus pneumoniae en atención primaria y factores asociados a la colonización 2015 ·Enfermedades Infecciosas y Microbiología Clínica ·(unknown), Jesús Almeda, (unknown), Mariona Pons‐Vigués, Rosa Morros, (unknown), Pere Simonet, Casper D. J. den Heijer, Bonaventura Bolíbar	7
14	Traitement par injections d’acide polylactique (Newfill®) des lipoatrophies faciales chez les malades infectés par le VIH 2006 ·Annales de Dermatologie et de Vénéréologie ·Isaac Bodokh, Pere Simonet	5
15	Certification of occupational diseases as common diseases in a primary health care setting 2005 ·American Journal of Industrial Medicine ·Fernando G. Benavides, (unknown), David Gimeno, Miquel Porta, (unknown), Pere Simonet	24
16	Variable Virological Outcomes According to the Center Providing Antiretroviral Therapy Within the PharmAdapt Clinical Trial 2003 ·HIV Clinical Trials ·Philippe Clevenbergh, Marie‐Cécile Bozonnat, Myriam Kirstetter, J. Durant, Éric Cua, P. Del Giudice, N Montagne, Pere Simonet, P. Dellamonica, (unknown)	4
17	Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica 2001 ·Archivos de Bronconeumología ·Alvarez-Sala Jl, (unknown), Juan F. Masa, Marc Miravitlles, Jesús Molina, Karlos Naberán, Pere Simonet, José Luís Viejo	61
18	Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica 2001 ·Atención Primaria ·Alvarez-Sala Jl, (unknown), Jesús Molina, (unknown), Pere Simonet, J.F. Masa Jiménez, (unknown), (unknown)	4
19	Situación diagnóstica del cáncer de próstata en atención primaria 2000 ·Atención Primaria ·(unknown), Pere Simonet, (unknown), (unknown), (unknown)	3
20	Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial breakdown → 1999 ·The Lancet ·J. Durant, Philippe Clevenbergh, Philippe Halfon, Pascal Del-Giudice, (unknown), Pere Simonet, N Montagne, CAB Boucher, (unknown), P. Dellamonica	559

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact